$DATS
DatChat, Inc. Stock $dats

$dats Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000121390023025416 Filed on March 31, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$154.00	$3.920K	$46.21K
YoY Change	-80.99%	-11.91%	938.52%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$2.117M	$2.336M	$10.55M
YoY Change	-37.16%	-68.21%	-2.71%
% of Gross Profit
Research & Development	$346.6K	$256.0K	$515.0K
YoY Change
% of Gross Profit
Depreciation & Amortization	$5.780K	$60.27K	$127.5K
YoY Change	63.28%	2497.84%	5395.69%
% of Gross Profit
Operating Expenses	$346.6K	$2.592M	$515.0K
YoY Change	-89.71%	-64.72%	-95.25%
Operating Profit	-$2.486M		-$12.23M
YoY Change	-26.17%		12.81%
Interest Expense	-$19.43K	$63.26K
YoY Change	-1292.02%	2711.56%
% of Operating Profit
Other Income/Expense, Net	$87.10K		$88.15K
YoY Change	5233.99%
Pretax Income	-$2.399M	-$3.534M	-$12.14M
YoY Change	-28.72%	-51.82%	12.09%
Income Tax
% Of Pretax Income
Net Earnings	-$2.399M	-$3.534M	-$12.14M
YoY Change	-28.72%	-51.82%	12.09%
Net Earnings / Revenue	-1557931.17%	-90160.97%	-26266.01%
Basic Earnings Per Share	-$0.12		-$0.60
Diluted Earnings Per Share	-$0.60	-$0.17	-$0.60
COMMON SHARES
Basic Shares Outstanding	20.23M shares	20.60M shares	20.10M shares
Diluted Shares Outstanding	20.10M shares		20.10M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.84M	$12.74M	$12.74M
YoY Change	-38.89%	-36.93%	-36.93%
Cash & Equivalents	$756.5K	$1.733M
Short-Term Investments	$10.08M	$11.01M	$11.01M
Other Short-Term Assets	$254.1K	$134.8K	$134.8K
YoY Change	-17.05%	-64.25%	-64.25%
Inventory
Prepaid Expenses		$134.8K
Receivables	$422.00	$384.00	$380.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$11.10M	$12.88M	$12.88M
YoY Change	-38.52%	-37.42%	-37.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$73.91K	$79.69K	$214.2K
YoY Change	-69.84%	48.35%	-10.0%
Goodwill
YoY Change
Intangibles		$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$23.38K	$23.38K
YoY Change
Total Long-Term Assets	$194.4K	$237.6K	$237.6K
YoY Change	-20.66%	-0.18%	-0.18%
TOTAL ASSETS
Total Short-Term Assets	$11.10M	$12.88M	$12.88M
Total Long-Term Assets	$194.4K	$237.6K	$237.6K
Total Assets	$11.29M	$13.11M	$13.11M
YoY Change	-38.28%	-37.0%	-37.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$450.6K	$404.6K	$404.6K
YoY Change	28.71%	-21.75%	-21.75%
Accrued Expenses	$71.17K	$67.34K	$67.34K
YoY Change	24.84%	24.94%	24.94%
Deferred Revenue	$135.00	$186.00
YoY Change		-97.9%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$521.8K	$473.4K	$473.4K
YoY Change	25.71%	-18.37%	-18.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$64.30K	$83.68K	$83.68K
YoY Change	-52.53%	-44.59%	-44.59%
Total Long-Term Liabilities	$64.30K	$83.68K	$83.68K
YoY Change	-52.53%	-44.59%	-44.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$521.8K	$473.4K	$473.4K
Total Long-Term Liabilities	$64.30K	$83.68K	$83.68K
Total Liabilities	$586.1K	$557.1K	$557.1K
YoY Change	6.46%	-23.79%	-23.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$42.13M	-$39.73M
YoY Change		44.0%
Common Stock	$2.074K	$2.060K
YoY Change		5.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$311.2K
YoY Change
Treasury Stock Shares
Shareholders Equity	$10.70M	$12.56M	$12.56M
YoY Change
Total Liabilities & Shareholders Equity	$11.29M	$13.11M	$13.11M
YoY Change	-38.28%	-37.0%	-37.0%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$2.399M	-$3.534M	-$12.14M
YoY Change	-28.72%	-51.82%	12.09%
Depreciation, Depletion And Amortization	$5.780K	$60.27K	$127.5K
YoY Change	63.28%	2497.84%	5395.69%
Cash From Operating Activities	-$1.760M	-$1.531M	-$7.259M
YoY Change	-21.13%	-74.21%	-14.14%
INVESTING ACTIVITIES
Capital Expenditures		-$233.2K	$44.48K
YoY Change		316.2%	-179.36%
Acquisitions
YoY Change
Other Investing Activities	$1.095M	-$3.200M	-$11.16M
YoY Change
Cash From Investing Activities	$1.095M	-$2.967M	-$11.21M
YoY Change	-583.97%	5194.56%	19902.01%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$312.5K	1.310K	$1.112K
YoY Change	156144.5%	-99.65%	-100.0%
NET CHANGE
Cash From Operating Activities	-$1.760M	-1.531M	-$7.259M
Cash From Investing Activities	$1.095M	-2.967M	-$11.21M
Cash From Financing Activities	-$312.5K	1.310K	$1.112K
Net Change In Cash	-$976.6K	-4.497M	-$18.47M
YoY Change	-60.26%	-19.92%	-194.66%
FREE CASH FLOW
Cash From Operating Activities	-$1.760M	-$1.531M	-$7.259M
Capital Expenditures		-$233.2K	$44.48K
Free Cash Flow	-$1.760M	-$1.298M	-$7.303M
YoY Change	-12.22%	-77.93%	-13.04%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-40729
CY2022	dei	Entity Registrant Name EntityRegistrantName	DATCHAT, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2502264
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	204 Nielson Street
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	New Brunswick
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08901
CY2022	dei	City Area Code CityAreaCode	(732)
CY2022	dei	Local Phone Number LocalPhoneNumber	374-3529
CY2022	dei	Security12b Title Security12bTitle	Common Stock, par value $0.0001 per share
CY2022	dei	Trading Symbol TradingSymbol	DATS
CY2022	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	17847418	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20234066	shares
CY2022	dei	Auditor Firm AuditorFirmId	4048
CY2022	dei	Auditor Name AuditorName	D. Brooks and Associates CPAs, P.A
CY2022	dei	Auditor Location AuditorLocation	Palm Beach Gardens, Florida
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	1732956	usd
CY2021Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	20199735	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	11007997	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	384	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	278	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	134752	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	376973	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12876089	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	20576986	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79694	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	53720	usd
CY2022Q4	dats	Digital Currencies And Other Digital Assets DigitalCurrenciesAndOtherDigitalAssets	23381	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	134526	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	184309	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	237601	usd
CY2021Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	238029	usd
CY2022Q4	us-gaap	Assets Assets	13113690	usd
CY2021Q4	us-gaap	Assets Assets	20815015	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	404600	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	517039	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	67338	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	53897	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	186	usd
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8850	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	1315	usd
CY2021Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	203	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	473439	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	579989	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83675	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	151012	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	83675	usd
CY2021Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	151012	usd
CY2022Q4	us-gaap	Liabilities Liabilities	557114	usd
CY2021Q4	us-gaap	Liabilities Liabilities	731001	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	20597169	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	20597169	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19597169	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19597169	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2060	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1960	usd
CY2022Q4	dats	Common Stock To Be Issued CommonStockToBeIssued	1389	shares
CY2021Q4	dats	Common Stock To Be Issued CommonStockToBeIssued	1389	shares
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52283634	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	47672600	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39729118	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-27590546	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12556576	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20084014	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13113690	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	20815015	usd
CY2022	us-gaap	Revenues Revenues	46214	usd
CY2021	us-gaap	Revenues Revenues	4445	usd
CY2022	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	6551776	usd
CY2021	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	2963294	usd
CY2022	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	828736	usd
CY2021	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	5090763	usd
CY2022	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	2285312	usd
CY2021	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	2181317	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	514957	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	991882	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	607621	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	981000	usd
CY2022	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	119276	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	12272939	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	10842995	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-12226725	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-10838550	usd
CY2021	us-gaap	Interest Expense InterestExpense	127	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	12305	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	3516	usd
CY2021	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	6127	usd
CY2022	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	28176	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	47672	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	88153	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	9516	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12138572	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10829034	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.6
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.71
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	20104268	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15334338	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	582325	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	13671074	usd
CY2021	dats	Stock Issued During Period Value Common Stock Issued For Exercise Of Series A Warrants StockIssuedDuringPeriodValueCommonStockIssuedForExerciseOfSeriesAWarrants	14356272	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Dividend StockIssuedDuringPeriodValueStockDividend	420000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	1533377	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition	350000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10829034	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20084014	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3173401	usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation Forfeited StockGrantedDuringPeriodValueSharebasedCompensationForfeited	347733	usd
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1090000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12138572	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12556576	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-12138572	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-10829034	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	127501	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2319	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	49783	usd
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	43221	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	3173401	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1090027	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	347733	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1213350	usd
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	6127	usd
CY2022	us-gaap	Asset Impairment Charges AssetImpairmentCharges	981000	usd
CY2022	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-119276	usd
CY2022	dats	Noncash Digital Currency And Other Digital Assets Fees NoncashDigitalCurrencyAndOtherDigitalAssetsFees	13739	usd
CY2022	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	36394	usd
CY2022	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	28176	usd
CY2022	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	47672	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	106	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	278	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-242221	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	351713	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	61	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	397502	usd
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-8664	usd
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	8850	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-53896	usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-22621	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-7258765	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-8454504	usd
CY2022	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9910000	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	20842149	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44475	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	56039	usd
CY2022	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets	743	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	233245	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-11209126	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-56039	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	20294	usd
CY2021	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	177624	usd
CY2022	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-19182	usd
CY2021	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-177615	usd
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	7500	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	14356272	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	13671074	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1112	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	28019855	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18466779	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	19509312	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20199735	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	690423	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1732956	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20199735	usd
CY2022	dats	Intangible Assets Used To Pay Accounts Payable IntangibleAssetsUsedToPayAccountsPayable	112500	usd
CY2021	dats	Common Stock Issued For Future Services CommonStockIssuedForFutureServices	50000	usd
CY2022	dats	Issuance Of Common Shares For Intangible Assets IssuanceOfCommonSharesForIntangibleAssets	1090000	usd
CY2022Q2	dats	Number Of Acquisition Share NumberOfAcquisitionShare	1000000	shares
CY2021	dats	Subscription Revenues SubscriptionRevenues	4445	usd
CY2022	dats	Nft Revenues NFTRevenues	36394	usd
CY2022	dats	Net Realized Investment Gains NetRealizedInvestmentGains	47672	usd
CY2022Q4	us-gaap	Other Short Term Investments OtherShortTermInvestments	28176	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	12138572	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	10829034	usd
CY2022Q4	us-gaap	Cash Including Discontinued Operations CashIncludingDiscontinuedOperations	7258765	usd
CY2021Q4	us-gaap	Cash Including Discontinued Operations CashIncludingDiscontinuedOperations	8454504	usd
CY2022Q4	dats	Accumulated Deficit For The Period AccumulatedDeficitForThePeriod	39729118	usd
CY2021	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	13700000	usd
CY2021	dats	Gross Proceeds Of Ipo GrossProceedsOfIPO	14400000	usd
CY2022	dats	Working Capitals WorkingCapitals	12402650	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Use of estimates</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the consolidated financial statements and during the reporting period. Actual results could materially differ from these estimates. Significant estimates include assumptions used in assessing impairment of long-term assets, the valuation of intangible assets, the valuation of digital currencies and other digital assets, the valuation of deferred tax assets, and the fair value of non-cash equity transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
CY2022	dats	Operating Lease Impairmentloss OperatingLeaseImpairmentloss	119276	usd
CY2022	dats	Subscription Revenues SubscriptionRevenues	9820	usd
CY2022	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	46214	usd
CY2021	us-gaap	Revenues Net Of Interest Expense RevenuesNetOfInterestExpense	4445	usd
CY2022	dats	Related Party Amount RelatedPartyAmount	514957	usd
CY2022Q4	dats	Advertising Costs AdvertisingCosts	828736	usd
CY2021Q4	dats	Advertising Costs AdvertisingCosts	5090763	usd
CY2022	dats	Largest Amount Of Tax Benefit LargestAmountOfTaxBenefit	0.50	pure
CY2022	dats	Common Stock Warrants CommonStockWarrants	673841	shares
CY2021	dats	Common Stock Warrants CommonStockWarrants	736341	shares
CY2022	dats	Common Stock Options CommonStockOptions	1604200	shares
CY2021	dats	Common Stock Options CommonStockOptions	1054200	shares
CY2022	dats	Commonstockequivalents Commonstockequivalents	2278041	shares
CY2021	dats	Commonstockequivalents Commonstockequivalents	1790541	shares
CY2022	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><span style="text-decoration:underline">Reclassification</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Certain reclassifications have been made in the consolidated financial statements to conform to the current year presentation. Such reclassifications had no impact on the Company’ previously reported consolidated financial position or results of operations. Specifically, on the consolidated statements of operations, certain operating expenses that were classified as general and administrative expenses were reclassified to professional and consulting fees.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b> </b></p>
CY2022	us-gaap	Short Term Lease Cost ShortTermLeaseCost	10960325	usd
CY2022	dats	Unrealized Gains Loss On Investments UnrealizedGainsLossOnInvestments	47672	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	11007997	usd
CY2019Q1	us-gaap	Operating Expenses OperatingExpenses	2567	usd
CY2021Q4	dats	Expired Term ExpiredTerm	2024-12-31
CY2021Q4	us-gaap	Advance Rent AdvanceRent	7156	usd
CY2022Q4	us-gaap	Derivative Fixed Interest Rate DerivativeFixedInterestRate	0.03	pure
CY2022	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	94924	usd
CY2021	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	78280	usd
CY2021Q3	dats	Operating Lease Rightof Use Asset And Liabilities OperatingLeaseRightofUseAssetAndLiabilities	198898	usd
CY2022Q4	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P39M
CY2022	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.18	pure
CY2022Q4	dats	Office Lease OfficeLease	198898	usd
CY2021Q4	dats	Office Lease OfficeLease	271507	usd
CY2022Q4	dats	Accumulated Amortizations AccumulatedAmortizations	-64372	usd
CY2021Q4	dats	Accumulated Amortizations AccumulatedAmortizations	-87198	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	134526	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	184309	usd
CY2022Q4	dats	Office Leases OfficeLeases	198898	usd
CY2021Q4	dats	Office Leases OfficeLeases	271507	usd
CY2022Q4	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-47885	usd
CY2021Q4	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-66598	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	151013	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	204909	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	67338	usd
CY2021Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	53897	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83675	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	151012	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Two LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo	89193	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due In Rolling Year Three LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree	92100	usd
CY2022Q4	dats	Operating Leases Future Minimum Payment Due OperatingLeasesFutureMinimumPaymentDue	181293	usd
CY2022Q4	dats	Present Value Discount PresentValueDiscount	-30280	usd
CY2022Q4	dats	Total Operating Lease Liability TotalOperatingLeaseLiability	151013	usd
CY2022Q2	dats	Aggregate Of Shares AggregateOfShares	1000000	shares
CY2022Q2	dats	Acquisition Share Value AcquisitionShareValue	1090000	usd
CY2022Q2	dats	Share Prices SharePrices	1.09
CY2022Q2	us-gaap	Fiscal Period Duration FiscalPeriodDuration	P5Y
CY2022	us-gaap	Acquisition Costs AcquisitionCosts	1090000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	109000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-981000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	109000	usd
CY2022Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	1315	usd
CY2021Q4	us-gaap	Other Long Term Notes Payable OtherLongTermNotesPayable	203	usd
CY2022	dats	Working Capital WorkingCapital	20294	usd
CY2021	dats	Working Capital WorkingCapital	177624	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	19182	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	177615	usd
CY2022	us-gaap	Payments For Software PaymentsForSoftware	514957	usd
CY2022Q4	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	200000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	180000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2021Q3	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	On July 28, 2021, the Company filed a certificate of change to the Company’s amended and restated certificate of incorporation, with the Secretary of State of the State of Nevada, to effectuate a one-for-two (1:2) reverse stock split of the Company’s common stock.
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2000000	shares
CY2016Q3	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	In August 2016, the Company designated 1 share of Series A Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”) and has a stated value equal to $1.00 as may be adjusted for any stock dividends, combinations or splits. Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote divided by (y) forty-nine one hundredths (0.49) minus (z) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote.
CY2021	dats	Company Sold Aggregate Shares CompanySoldAggregateShares	405224	shares
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1389	shares
CY2021Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	1389	shares
CY2021Q3	us-gaap	Proceeds From Other Debt ProceedsFromOtherDebt	13800000	usd
CY2021Q3	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	1718000	usd
CY2021Q3	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	12081837	usd
CY2022Q4	us-gaap	Loans Held For Sale Term LoansHeldForSaleTerm	P5Y
CY2022	dats	Issuance At Exercise Price Per Share IssuanceAtExercisePricePerShare	4.98
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares To Be Repurchased Next Year ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesToBeRepurchasedNextYear	231325	shares
CY2022	us-gaap	Debt Instrument Redemption Price Percentage DebtInstrumentRedemptionPricePercentage	0.08	pure
CY2022Q4	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	4.98
CY2021Q1	dats	Stock Issued During Period Share Issued For Services StockIssuedDuringPeriodShareIssuedForServices	105000	shares
CY2021Q1	dats	Common Share Fair Values CommonShareFairValues	420000	usd
CY2021Q1	dats	Per Share Based On Sales PerShareBasedOnSales	4
CY2021Q1	dats	Stock Based Consulting StockBasedConsulting	420000	usd
CY2021Q1	dats	Aggreement Issued Shares AggreementIssuedShares	100000	shares
CY2021Q1	dats	Common Share Fair Values CommonShareFairValues	400000	usd
CY2021Q1	dats	Per Share Based On Sales PerShareBasedOnSales	4
CY2021Q1	dats	Stock Based Consulting StockBasedConsulting	350000	usd
CY2021	dats	Remaining Balance Of Stock Based Consulting RemainingBalanceOfStockBasedConsulting	50000	usd
CY2022	dats	Number Of Restricted Shares NumberOfRestrictedShares	1000000	shares
CY2022Q4	us-gaap	Business Acquisition Cost Of Acquired Entity Transaction Costs BusinessAcquisitionCostOfAcquiredEntityTransactionCosts	1090000	usd
CY2021Q3	dats	Gross Proceeds GrossProceeds	14356272	usd
CY2021Q4	dats	Warrant Exercisable Shares WarrantExercisableShares	2882785	shares
CY2021Q4	dats	Aggregate Issuance AggregateIssuance	2882785	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	62500	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.4
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y7M2D
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	3556626	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.98
CY2021	dats	Weighted Average Remaining Contractual Life Years Granted WeightedAverageRemainingContractualLifeYearsGranted	P4Y7M24D
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	2882785	shares
CY2021	dats	Weighted Average Exercise Price Exercised WeightedAverageExercisePriceExercised	4.98
CY2021	dats	Weighted Average Remaining Contractual Life Years Exercised WeightedAverageRemainingContractualLifeYearsExercised	P4Y7M24D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	736341	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.59
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y3M18D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExpirations	62500	shares
CY2022	dats	Weighted Average Exercise Price Cancelledin Dollars Per Share WeightedAverageExercisePriceCancelledinDollarsPerShare	0.4
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	673841	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	4.98
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y7M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	673841	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Other Share Increase Decrease In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOtherShareIncreaseDecreaseInPeriodWeightedAverageExercisePrice	4.98
CY2022	dats	Weighted Average Remaining Contractual Life Years Warrants Exercisable WeightedAverageRemainingContractualLifeYearsWarrantsExercisable	P3Y7M24D
CY2022Q4	dats	Common Stock Share Issued CommonStockShareIssued	0	shares
CY2021Q3	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	285700	shares
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4.15
CY2021Q3	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	530000	shares
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	6.25
CY2021Q3	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	18500	shares
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2021Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	14.25
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2021Q4	dats	Stock Issued During Period Shares Issued For Service StockIssuedDuringPeriodSharesIssuedForService	25000	usd
CY2021	dats	Severance Fees SeveranceFees	35000	usd
CY2021Q3	us-gaap	Shares Held In Employee Stock Option Plan Committed To Be Released SharesHeldInEmployeeStockOptionPlanCommittedToBeReleased	10000	shares
CY2021Q3	us-gaap	Shares Held In Employee Stock Option Plan Allocated SharesHeldInEmployeeStockOptionPlanAllocated	140000	shares
CY2021Q3	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	115000	shares
CY2021Q3	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	25000	shares
CY2021Q4	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	10000	shares
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	7139392	usd
CY2021Q4	dats	Additional Shares Issued Description AdditionalSharesIssuedDescription	On December 26, 2021 and effective January 10, 2022, the Company approved the grant of 150,000 options to purchase the Company’s common stock to a newly hired employee of the Company.
CY2021Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2022	us-gaap	Stock Option Exercise Price Decrease StockOptionExercisePriceDecrease	4
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2022Q3	dats	Granted Aggregate Options Shares GrantedAggregateOptionsShares	325000	shares
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	4
CY2022Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage	0.25	pure
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised Net Of Tax Benefit Expense StockIssuedDuringPeriodValueStockOptionsExercisedNetOfTaxBenefitExpense	751681	usd
CY2021	dats	Stock Based Expense StockBasedExpense	1533377	usd
CY2021	us-gaap	Professional Fees ProfessionalFees	443350	usd
CY2022	dats	Stock Based Expense StockBasedExpense	3471134	usd
CY2022	us-gaap	Professional Fees ProfessionalFees	297733	usd
CY2022	dats	Stock Issued During Period Shares Issued For Service StockIssuedDuringPeriodSharesIssuedForService	2532367	usd
CY2022	dats	Weighted Average Period WeightedAveragePeriod	P1Y18D
CY2021	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Term1 ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedTerm1	P3Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2022	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	10000000	usd
CY2022	dats	Compensation Of Total Gross Proceeds CompensationOfTotalGrossProceeds	0.08	pure
CY2022	dats	Shares Of Common Stock Sold In The Offering sharesOfCommonStockSoldInTheOffering	0.08	pure
CY2022	dats	Public Offering PublicOffering	1.10	pure
CY2022	dats	Broker Cash Fee Percentage BrokerCashFeePercentage	0.10	pure
CY2022	dats	Broker Cash Fee Percentage Of Debt Placements BrokerCashFeePercentageOfDebtPlacements	0.06	pure
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Shares Purchased For Award ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward	3325301	shares
CY2021Q3	dats	Common Stock For Gross Proceed CommonStockForGrossProceed	13800000	usd
CY2021Q3	dats	Percentage Of Gross Proceeds PercentageOfGrossProceeds	0.08	pure
CY2021Q3	dats	Percentage Of Warrants PercentageOfWarrants	0.08	pure
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1000000	usd
CY2021	us-gaap	Marketing Expense MarketingExpense	3000000	usd
CY2021Q3	dats	Employment Agreement Description EmploymentAgreementDescription	the Company entered into an agreement (the “Employment Agreement”) with Darin Myman effective as of August 15, 2021 pursuant to which Mr. Myman’s (i) base salary will increase to $450,000 per year, and (ii) Mr. Myman shall be entitled to receive an annual bonus in an amount up to $350,000, which annual bonus may be increased by the Compensation Committee of the Board of Directors of the Company (the “Compensation Committee”), in its sole discretion, upon the achievement of additional criteria established by the Compensation Committee from time to time (the “Annual Bonus”). The Employment Agreement provides for a term of one (1) year (the “Initial Term”) from the date of the Effective Date and shall automatically be extended for additional terms of one (1) year each (each a “Renewal Term”) unless either party gives prior written notice of non-renewal to the other party no later than six (6) months prior to the expiration of the Initial Term, or the then current Renewal Term, as the case may be. In addition, pursuant to the Employment Agreement, upon termination of Mr. Myman’s employment for death or Total Disability (as defined in the Employment Agreement), in addition to any accrued but unpaid compensation and vacation pay through the date of his termination and any other benefits accrued to him under any Benefit Plans (as defined in the Employment Agreement) outstanding at such time and the reimbursement of documented, unreimbursed expenses incurred prior to such termination date (collectively, the “Payments”), Mr. Myman shall be entitled to the following severance benefits: (i) 24 months of his then base salary; (ii) if Mr. Myman elects continuation coverage for group health coverage pursuant to COBRA Rights (as defined in the Employment Agreement), then for a period of 24 months following Mr. Myman’s termination he will be obligated to pay only the portion of the full COBRA Rights cost of the coverage equal to an active employee’s share of premiums (if any) for coverage for the respective plan year; and (iii) payment on a pro-rated basis of any Annual Bonus or other payments earned in connection with any bonus plan to which Mr. Myman was a participant as of the date of his termination (together with the Payments, the “Severance”). Furthermore, pursuant to the Employment Agreement, upon Mr. Myman’s termination (i) at his option (A) upon 90 days prior written notice to the Company or (B) for Good Reason (as defined in the Employment Agreement), (ii) termination by the Company without Cause (as defined in the Employment Agreement) or (iii) termination of Mr. Myman’s employment within 40 days of the consummation of a Change in Control Transaction (as defined in the Employment Agreement), Mr. Myman shall receive the Severance; provided, however, Mr. Myman shall be entitled to a pro-rated Annual Bonus of at least $200,000. In addition, any equity grants issued to Mr. Myman shall immediately vest upon termination of Mr. Myman’s employment by him for Good Reason or by the Company at its option upon 90 days prior written notice to Mr. Myman, without Cause.
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	1
CY2022Q4	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	1
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	20636324	usd
CY2022Q4	srt	Financing Receivable Allowance For Credit Loss To Nonaccrual Percent FinancingReceivableAllowanceForCreditLossToNonaccrualPercent	1	pure
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2549100	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-2274097	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-606929	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-541452	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	1170555	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	598878	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1985474	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	2216671	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	5365445	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	3379971	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	5365445	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	3379971	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	20636324	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration	1403306	usd
CY2022	dats	Expire Year ExpireYear	P2034Y
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19233018	usd
CY2022Q4	us-gaap	Income Tax Examination Increase Decrease In Liability From Prior Year IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear	1985474	usd
CY2021Q4	us-gaap	Income Tax Examination Increase Decrease In Liability From Prior Year IncomeTaxExaminationIncreaseDecreaseInLiabilityFromPriorYear	2216671	usd
CY2021Q4	us-gaap	Short Term Investments ShortTermInvestments		usd
CY2021Q4	dats	Digital Currencies And Other Digital Assets DigitalCurrenciesAndOtherDigitalAssets		usd
CY2022Q4	dats	Preferred Stock Value1 PreferredStockValue1		usd
CY2021Q4	dats	Preferred Stock Value1 PreferredStockValue1		usd
CY2022Q4	dats	Common Stockvalueone CommonStockvalueone		usd
CY2021Q4	dats	Common Stockvalueone CommonStockvalueone		usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2021	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived		usd
CY2021	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2022	us-gaap	Interest Expense InterestExpense		usd
CY2021	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses		usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.71
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	20104268	shares
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2021	dats	Fractional Shares Due To Reverse Split FractionalSharesDueToReverseSplit		usd
CY2022	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets		usd
CY2021	dats	Noncash Digital Currency And Other Digital Assets Fees NoncashDigitalCurrencyAndOtherDigitalAssetsFees		usd
CY2021	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives		usd
CY2021	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments		usd
CY2021	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments		usd
CY2021	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments		usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments		usd
CY2021	us-gaap	Proceeds From Sale Of Productive Assets ProceedsFromSaleOfProductiveAssets		usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
CY2022	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet		usd
CY2022	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
CY2021	dats	Intangible Assets Used To Pay Accounts Payable IntangibleAssetsUsedToPayAccountsPayable		usd
CY2022	dats	Common Stock Issued For Future Services CommonStockIssuedForFutureServices		usd
CY2022	dats	Subscription Receivable From Exercise Of Series A Warrants SubscriptionReceivableFromExerciseOfSeriesAWarrants		usd
CY2021	dats	Subscription Receivable From Exercise Of Series A Warrants SubscriptionReceivableFromExerciseOfSeriesAWarrants		usd
CY2021	dats	Issuance Of Common Shares For Intangible Assets IssuanceOfCommonSharesForIntangibleAssets		usd
CY2021	dats	Nft Revenues NFTRevenues		usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
CY2022	dats	Weighted Average Remaining Contractual Life Years Cancelled WeightedAverageRemainingContractualLifeYearsCancelled
CY2022	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate		pure
CY2021	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate		pure
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001648960

Files In Submission

Name	View Source	Status
0001213900-23-025416-index-headers.html	Edgar Link	pending
0001213900-23-025416-index.html	Edgar Link	pending
0001213900-23-025416.txt	Edgar Link	pending
0001213900-23-025416-xbrl.zip	Edgar Link	pending
dats-20221231.xsd	Edgar Link	pending
f10k2022ex23-1_datchatinc.htm	Edgar Link	pending
f10k2022ex31-1_datchatinc.htm	Edgar Link	pending
f10k2022ex31-2_datchatinc.htm	Edgar Link	pending
f10k2022ex32-1_datchatinc.htm	Edgar Link	pending
f10k2022_datchatinc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
image_002.jpg	Edgar Link	pending
image_003.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
dats-20221231_def.xml	Edgar Link	unprocessable
dats-20221231_lab.xml	Edgar Link	unprocessable
dats-20221231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
f10k2022_datchatinc_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dats-20221231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DATS
DatChat, Inc. Stock $dats

2023 Q1 Form 10-K Financial Statement

#000121390023025416 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS DatChat, Inc. Stock $dats

2023 Q1 Form 10-K Financial Statement

#000121390023025416 Filed on March 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS
DatChat, Inc. Stock $dats